CollPlant Biotechnologies Ltd.
CLGN
$2.35
-$0.07-2.89%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | 58.53% | 58.70% | |
| Total Depreciation and Amortization | -- | -- | 2.42% | 10.54% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | -14.43% | -7.81% | |
| Change in Net Operating Assets | -- | -- | 255.88% | -1,340.00% | |
| Cash from Operations | -- | -- | 79.83% | 70.53% | |
| Capital Expenditure | -- | -- | 25.12% | 29.97% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -100.89% | -100.38% | |
| Cash from Investing | -- | -- | -104.00% | -105.80% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -40.88% | -6.68% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | -- | -40.88% | -6.68% | |
| Foreign Exchange rate Adjustments | -- | -- | 37.66% | 10.81% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | -119.35% | -154.34% | |